This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Compassion & Choices Applauds Vermont Senate's Important Vote To Advance Death With Dignity Bill

MONTPELIER, Vt., Feb. 12, 2013 /PRNewswire-USNewswire/ -- The Vermont Senate today voted 17-13 to override the Senate Judiciary Committee's recommendation on S.B. 48, a bill to allow mentally competent, terminally ill Vermonters the option of choosing aid in dying. The following statement can be attributed to Kathryn Tucker, Director of Legal Affairs for Compassion & Choices, the nation's oldest and largest nonprofit working to improve care and expand choice at the end of life. Tucker testified before the Senate Judiciary Committee in favor of the bill on February 6.

"Today's vote is an important step for patients, families and doctors who support choice and autonomy. The Vermont Senators' vote reflects the views of a great majority of Vermonters, who overwhelmingly support aid in dying. Citizens want to control their lives, up to the moment they die, without government interference in their private healthcare choices. Today's Senate vote supports giving individuals the opportunity to make deeply personal medical decisions based on their own values and beliefs.

"We are pleased that the full Senate will continue debate on the aid-in-dying measure. Beyond Vermont, end-of-life choice is advancing in at least seven other states this year.

"Compassion & Choices is proud to work alongside Patient Choices Vermont and our many supporters throughout the state who, along with Governor Peter Shumlin, were instrumental in this important legislative victory."

Compassion & Choices provides support, education and advocacy to improve care at the end of life. To request client services or for more information, call 800.247.7421 toll-free or visit www.CompassionAndChoices.org. All services are free of charge, and confidentiality is strictly protected.

Contact: Gwen Fitzgerald, gfitzgerald@compassionandchoices.org (O) 800.247.7421 or (M) 202-669-6587

SOURCE Compassion & Choices

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs